FFA
NUVA

Freedman Financial Associates’s NuVasive, Inc. NUVA Stock Holding History

Freedman Financial Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-77
Closed -$4K – 466
2022
Q1 		$4K Hold
77
– – ﹤0.01% 431
2021
Q4 		$4K Sell
77
-302
-80% -$16.4K ﹤0.01% 406
2021
Q3 		$23K Hold
379
– – 0.02% 279
2021
Q2 		$26K Hold
379
– – 0.02% 264
2021
Q1 		$25K Hold
379
– – 0.02% 273
2020
Q4 		$21K Buy
+379
New +$18.6K 0.02% 287

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Freedman Financial Associates's NUVA Position: Q2 2022 in Review

Freedman Financial Associates sold out of NuVasive, Inc. (NUVA) in Q2 2022, closing a stake of 77 shares — an estimated $4K sold.

Freedman Financial Associates first reported a position in NUVA in Q4 2020 and held it in 6 quarters. The position peaked at $26K in Q2 2021. 237 funds tracked by Wall St. Rank hold NUVA as of Q2 2022.

  • Freedman Financial Associates reported no remaining NuVasive, Inc. position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 77 NuVasive, Inc. shares in Q2 2022, an estimated $4K.
  • Freedman Financial Associates first reported a position in NuVasive, Inc. in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's NuVasive, Inc. position peaked at $26K in Q2 2021.
  • 237 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.